Table 6 Unadjusted and adjusted ORs for outcome (mortality and readmission) among women compared with men

	Men/Women (%)	Gender differences
	Men/Women (%)	Unadjusted OR (95% CI)	OR adjusted for age (95% CI)	Adjusted OR, patients with LVSD only, n = 3584 (95% CI)†	Adjusted OR, patients with PLVF only, n = 2396 (95% CI)†
12-week mortality	12.7/15.2	1.24 (1.10 to 1.39)	0.97 (0.86 to 1.10)	1.10 (0.88 to 1.38)	1.23 (0.93 to 1.64)
Readmissions during 12-week follow-up period	20.3/18.9	0.92 (0.83 to 1.02)	0.92 (0.82 to 1.02)	1.03 (0.86 to 1.23)	0.86 (0.70 to 1.05)

*OR >1 correlates with a higher prevalence in women.
†Adjusted for age, hypertension, diabetes, stroke or transient ischaemic attack (TIA), renal failure, respiratory disease, coronary artery disease, cardiomyopathy, and atrial fibrillation.